Abstract
Recent developments in nucleoside/nucleotide therapeutics and antiviral drug targets are described covering progress in the development of nucleoside/nucleotide mimetics for the treatment of influenza virus, human immunodeficiency virus type 1, hepatitis B and C virus, herpes virus infections; including herpes simplex virus, cytomegalovirus and varicella zoster virus infections, and the highly pathogenic poxviruses (variola, vaccinia and mokey pox) and filoviruses (Ebola and Marburg).
| Original language | English |
|---|---|
| Pages (from-to) | 1191-1203 |
| Number of pages | 13 |
| Journal | Current Topics in Medicinal Chemistry |
| Volume | 5 |
| Issue number | 13 |
| DOIs | |
| Publication status | Published - 2005 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antisense oligonucleotides
- Filovirus
- Hepatitis B and C virus
- Herpes virus
- Human immunodeficiency virus
- Influenza virus
- Nucleoside/nucleotide therapeutics
- Poxvirus
- siRNA
Fingerprint
Dive into the research topics of 'Recent advances in antiviral nucleoside and nucleotide therapeutics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver